Trial Profile
A Phase 2 Study of Intralesional PV-10 in the Treatment of Metastatic Melanoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2021
Price :
$35
*
At a glance
- Drugs Rose bengal sodium (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Provectus Biopharmaceuticals
- 27 Sep 2021 According to Provectus Biopharmaceuticals media release, data from this study will be presented on two poster presentations at the SMR 2021 Congress (the Society for Melanoma Research annual meeting).
- 01 Oct 2014 According to company's website, results published in the Annals of Surgical Oncology (Title- Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma).
- 29 Sep 2014 Data from overall analysis and sub-group data were announced in Provectus biopharmaceuticals media release.